| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |